Scienture Holdings, Inc. (SCNX): Total Liabilities
$14.06M
As of 2025-12-31
$23.63M
As of 2026-06-30
+61.0%
3-year compound annual growth
+66.1%
5-year compound annual growth
+23.1%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.06M | -45.5% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $25.78M | +115.0% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $11.99M | +256.1% | 2025-03-26, Balance as of period end |
| 2022-12-31 | $3.37M | +68.7% | 2024-04-22, Balance as of period end |
| 2021-12-31 | $2.00M | +79.2% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $1.11M | -22.2% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $1.43M | +3.5% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $1.38M | +48.8% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $929.4K | -37.4% | 2019-03-22, Balance as of period end |
| 2016-12-31 | $1.49M | -15.6% | 2018-03-02, Balance as of period end |
| 2015-12-31 | $1.76M | +218.0% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $553.7K | n/a | 2016-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $754.4K | +74.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $4.69M | -37.6% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $69.14M | +0.8% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $2.40M | -83.8% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
Compare SCNX, MNOV, MREO, LIPO side by side · Screen every company in Pharmaceutical Preparations ↗